GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 118 participants.
Also called NCT04942756
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 118 participants
- Sponsor
- Registry
-
NCT04942756
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Israel, Italy, Switzerland
- Registry status
- Unknown status
Technical summary
Registry record NCT04942756. Randomized; no masking; primary purpose supportive care. Start 2021-06-30 (actual); primary completion 2022-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.
- Condition
- Palliative Care
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Diabetes Mellitus, Type 1
- Condition
- Diabetes
- Condition
- Cancer
- Condition
- Terminal Cancer
- Condition
- Terminal Illness
- Condition
- End Stage Cancer
- Condition
- Advanced Cancer
- Intervention (Device)
- Continuous Glucose Monitoring
- Intervention (Device)
- Standard Care
- Lead sponsor
- Antea Foundation
- Collaborator
- Abbott Diabetes Care
Record details
- Record id
cardio:ct-nct04942756- Content hash
5a85e533520624f27cb311c30ab9c89d151fc7c2c39a2148cf67054fbd5bcaba